Literature DB >> 20662543

Synthesis and antiproliferative evaluation of certain indeno[1,2-c]quinoline derivatives. Part 2.

Chih-Hua Tseng1, Cherng-Chyi Tzeng, Chiao-Li Yang, Pei-Jung Lu, Hui-Ling Chen, Hao-Yi Li, You-Chung Chuang, Chia-Ning Yang, Yeh-Long Chen.   

Abstract

Certain indeno[1,2-c]quinoline derivatives were synthesized and evaluated for their antiproliferation, DNA binding affinity, and topoisomerases (topo I and topo II) inhibitory activities. The preliminary results are the following: (1) substituent of the aminoalkoxyimino side chain at C11 is important for antiproliferative activities in which the terminal amine preferred to be a tertiary or the cyclic five-membered pyrrolidino ring; (2) among the indeno[1,2-c]quinoline derivatives evaluated, (E)-6-hydroxy-9-methoxy-11H-indeno[1,2-c]quinolin-11-one O-2-(pyrrolidin-1-yl)ethyl oxime (8c) was found to be one of the most cytotoxic agents with a GI50 value of 0.84, 0.89, and 0.79 microM against SAS, A549, and BT483, respectively, which is more active than camptothecin; (3) substituent at C6 is crucial for the selective cytotoxicity in which the OH group is the most preferred while hydrogen or piperazine exhibited cytotoxicity on both cancer cells and Detroit-551; (4) a positive correlation of antiproliferative activity, DNA binding affinity, and topo I and topo II inhibitory activities has been observed for indeno[1,2-c]quinoline derivatives; (5) compound 8c induced DNA fragmentation may through caspase-3 activation, phosphorylation of the histone protein H2AX at Ser139 (gamma-H2AX), and PARP cleavage; (6) compound 8c demonstrated significant tumor regression in the human breast xenograft model; (7) indeno[1,2-c]quinoline derivatives are a new class of molecules that have the potential to be developed as dual topo I and topo II inhibitory agents.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20662543     DOI: 10.1021/jm1005447

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Structure-activity relationship study of copper(II) complexes with 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (4'-methylbenzoyl) hydrazone: synthesis, structures, DNA and protein interaction studies, antioxidative and cytotoxic activity.

Authors:  Duraisamy Senthil Raja; Nattamai S P Bhuvanesh; Karuppannan Natarajan
Journal:  J Biol Inorg Chem       Date:  2011-09-20       Impact factor: 3.358

2.  Synthesis of 1,5-benzothiazepine derivatives bearing 2-phenoxy-quinoline moiety via 1,3-diplolar cycloaddition reaction.

Authors:  Zhi-Qiang Dong; Fang-Ming Liu; Feng Xu; Zai-Liang Yuan
Journal:  Mol Divers       Date:  2011-08-12       Impact factor: 2.943

3.  Discovery of indeno[1, 2 - c] quinoline derivatives as dual topoisomerases I/II inhibitors: part 3.

Authors:  Chih-Hua Tseng; Cherng-Chyi Tzeng; Chiao-Li Yang; Pei-Jung Lu; Yu-Peng Liu; Hui-Ling Chen; Chien-Yu Chen; Chia-Ning Yang; Yeh-Long Chen
Journal:  Mol Divers       Date:  2013-11       Impact factor: 2.943

Review 4.  Tailored Quinolines Demonstrate Flexibility to Exert Antitumor Effects through Varied Mechanisms-A Medicinal Perspective.

Authors:  Sachin Sharma; Arshdeep Singh; Sahil Sharma; Ram Sharma; Jagjeet Singh; Nihar Kinarivala; Kunal Nepali; Jing P Liou
Journal:  Anticancer Agents Med Chem       Date:  2021       Impact factor: 2.527

5.  Three-Component Cascade Reaction of 1,1-Enediamines, N,N-Dimethylformamide Dimethyl Acetal, and 1,3-Dicarbonyl Compounds: Selective Synthesis of Diverse 2-Aminopyridine Derivatives.

Authors:  Quan-Xing Zi; Sheng-Jiao Yan; Chang-Long Yang; Kun Li; Jun Lin
Journal:  ACS Omega       Date:  2019-02-07

6.  Cascade Reaction of 1,1-Enediamines with 2-Benzylidene-1H-indene-1,3(2H)-diones: Selective Synthesis of Indenodihydropyridine and Indenopyridine Compounds.

Authors:  Qin Luo; Rong Huang; Qiang Xiao; Ling-Bin Kong; Jun Lin; Sheng-Jiao Yan
Journal:  ACS Omega       Date:  2019-04-11

7.  Design, synthesis and pharmacological evaluation of novel 2-chloro-3-(1H-benzo[d]imidazol-2-yl)quinoline derivatives as antitumor agents: in vitro and in vivo antitumor activity, cell cycle arrest and apoptotic response.

Authors:  Wen-Bin Kuang; Ri-Zhen Huang; Yi-Lin Fang; Gui-Bin Liang; Chen-Hui Yang; Xian-Li Ma; Ye Zhang
Journal:  RSC Adv       Date:  2018-07-06       Impact factor: 3.361

8.  BPIQ, a novel synthetic quinoline derivative, inhibits growth and induces mitochondrial apoptosis of lung cancer cells in vitro and in zebrafish xenograft model.

Authors:  Chien-Chih Chiu; Han-Lin Chou; Bing-Hung Chen; Kuo-Feng Chang; Chih-Hua Tseng; Yao Fong; Tzu-Fun Fu; Hsueh-Wei Chang; Chang-Yi Wu; Eing-Mei Tsai; Shinne-Ren Lin; Yeh-Long Chen
Journal:  BMC Cancer       Date:  2015-12-16       Impact factor: 4.430

9.  Dual roles of extracellular signal-regulated kinase (ERK) in quinoline compound BPIQ-induced apoptosis and anti-migration of human non-small cell lung cancer cells.

Authors:  Yao Fong; Chang-Yi Wu; Kuo-Feng Chang; Bing-Hung Chen; Wan-Ju Chou; Chih-Hua Tseng; Yen-Chun Chen; Hui-Min David Wang; Yeh-Long Chen; Chien-Chih Chiu
Journal:  Cancer Cell Int       Date:  2017-03-07       Impact factor: 5.722

10.  DFIQ, a Novel Quinoline Derivative, Shows Anticancer Potential by Inducing Apoptosis and Autophagy in NSCLC Cell and In Vivo Zebrafish Xenograft Models.

Authors:  Hurng-Wern Huang; Yung-Ding Bow; Chia-Yih Wang; Yen-Chun Chen; Pei-Rong Fu; Kuo-Feng Chang; Tso-Wen Wang; Chih-Hua Tseng; Yeh-Long Chen; Chien-Chih Chiu
Journal:  Cancers (Basel)       Date:  2020-05-25       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.